| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 05/17/2001 | WO2001034614A2 Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 05/17/2001 | WO2001034162A1 Anti-hiv compositions |
| 05/17/2001 | CA2391279A1 Synthesis of 2'-deoxy-l-nucleosides |
| 05/17/2001 | CA2390441A1 Combinatorial library synthesis and pharmaceutically active compounds produced thereby |
| 05/17/2001 | CA2390233A1 2-aminopurine derivatives |
| 05/15/2001 | US6232465 Nucleotide 5'-triphosphate having a removable blocking moiety protecting the 3' position and linked to the 3' carbon which is a hydrocarbyl, so a single phosphodiester linkage is formed between the initiating substrate and 5' nucleotide |
| 05/15/2001 | US6232463 Substituted purines and oligonucleotide cross-linking |
| 05/15/2001 | US6232462 Reduction of nonspecific hybridization by using novel base-pairing schemes |
| 05/15/2001 | US6232450 Inhibition of human fucosyltransferases with N-linked Lewis-x and LacNAc analogs |
| 05/15/2001 | US6232300 Administering as hepatitis b viricide |
| 05/15/2001 | US6232298 Administering uridine, cytidine, or orotic acid or salt or acylated derivative to treat cachexia |
| 05/15/2001 | US6232297 Methods and compositions for treating inflammatory response |
| 05/15/2001 | US6232075 Heterogeneous assay for pyrophosphate detection |
| 05/15/2001 | US6232071 Tenascin-C nucleic acid ligands |
| 05/10/2001 | WO2001032783A1 Water-soluble rhodamine dyes and conjugates thereof |
| 05/10/2001 | WO2001032671A1 Nucleoside derivatives with photolabile protecting groups |
| 05/10/2001 | WO2000078778A3 C-pyrazole a2a receptor agonists |
| 05/10/2001 | WO2000075154A3 Protected nucleosides |
| 05/10/2001 | CA2385262A1 Nucleoside derivatives with photolabile protecting groups |
| 05/09/2001 | EP1097939A2 Method for the synthesis of isoguanosine and its 2'-derivatives |
| 05/09/2001 | EP1097162A2 Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages |
| 05/09/2001 | CN1294133A Process for extracting cordycepin and its preparation |
| 05/08/2001 | US6229008 α-D-pentofuranosides, and a process for preparing the same |
| 05/08/2001 | US6228994 Labeled protein and its producing method, labeling compound to be used in the method, and method for analyzing function of genes |
| 05/08/2001 | US6228847 Inhibitors of nucleoside metabolism |
| 05/08/2001 | US6228020 Compliant hearing aid |
| 05/08/2001 | CA2032141C Pharmaceutically active agents that impede amyloid formation in vivo |
| 05/08/2001 | CA2029694C Heteroatoms-containing tricyclic compounds |
| 05/03/2001 | WO2001031051A2 Antisense modulation of protein kinase c-theta expression |
| 05/03/2001 | WO2001030395A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression |
| 05/03/2001 | WO2000057180A8 Use of lna in mass spectrometry |
| 05/03/2001 | DE19952113A1 Nucleosid-Derivate mit photolabilen Schutzgruppen Nucleoside derivatives with photolabile protecting groups |
| 05/02/2001 | EP1095947A1 Novel antibacterial compounds |
| 05/02/2001 | EP1095053A1 Arylsulfone linkers for mass spectrometric analysis |
| 05/02/2001 | EP0988304B1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
| 05/02/2001 | CN1065277C Process for preparation of avermectins |
| 05/01/2001 | US6225625 Signal detection methods and apparatus |
| 05/01/2001 | US6225460 Nucleotide analogs |
| 05/01/2001 | US6225450 Intact positively charged ionized mass-modified nucleic acid molecule |
| 05/01/2001 | CA2085703C 13-(substituted thio) acetoxymilbemycin derivatives, their preparation and their agrochemical uses |
| 04/26/2001 | WO2001029055A2 Novel oligosaccharides, preparation method and pharmaceutical compositions containing same |
| 04/26/2001 | WO2001029045A1 Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/26/2001 | WO2001028545A2 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 04/26/2001 | WO1997035591B1 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 04/26/2001 | CA2384573A1 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 04/25/2001 | CN1292795A Certain dinucleotides and their use as membrana mucosa cilium clearing and cilium vibration frequency regulating agent |
| 04/24/2001 | US6222030 Solid phase synthesis of oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection |
| 04/24/2001 | US6222025 Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom |
| 04/24/2001 | US6221851 Increasing cellular availability of adenosine. |
| 04/24/2001 | US6221606 Energy transfer dye comprising a donor dye which absorbs ight and emits exitation energy, an acceptor dye the absorbs the excitation energy and fluoresces in response, and a linker linking the two dyes, at least one is a dibenzorhodamine dye |
| 04/19/2001 | WO2001027131A1 Purine derivatives |
| 04/19/2001 | WO2001027130A1 Purine derivatives |
| 04/19/2001 | WO2001027114A1 PYRROLO[2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS |
| 04/19/2001 | WO2001026482A1 Polycyclic quinone and ionophore composition for the synergistic reduction of methane formation in ruminant animals |
| 04/19/2001 | WO2000075158A3 NOVEL 6-PHENYLPURINE 9-β-D-RIBONUCLEOSIDES WITH ANTINEOPLASTIC ACTIVITY, THEIR USE FOR PREPARING PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS |
| 04/19/2001 | CA2382732A1 Polycyclic quinone and ionophore composition for the synergistic reduction of methane formation in ruminant animals |
| 04/19/2001 | CA2381297A1 Pyrrolo¬2,3-d|pyrimidine nucleoside analogs |
| 04/18/2001 | CN1291615A 2', 3'-O-isopropylidennucleoside 5'-thiophosphamino acid ester compound |
| 04/17/2001 | US6218175 Nano-devices using block-copolymers |
| 04/17/2001 | CA2071483C Oligonucleotide analogs with novel linkages |
| 04/12/2001 | WO2001025248A2 Design of high affinity rnase h recruiting oligonucleotide |
| 04/12/2001 | WO2001025247A1 Compounds for protecting hydroxyls and methods for their use |
| 04/12/2001 | WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2 |
| 04/12/2001 | WO1999057117A3 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 04/12/2001 | CA2385853A1 Design of high affinity rnase h recruiting oligonucleotide |
| 04/11/2001 | EP1091001A1 Process for the purification of S-adenosyl-L-methionine and for the preparation of the pharmaceutically acceptable salts thereof |
| 04/11/2001 | EP1090023A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 04/11/2001 | EP1090022A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 04/11/2001 | EP1090021A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 04/11/2001 | EP1090020A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 04/11/2001 | EP1090019A1 Adenosine derivatives |
| 04/11/2001 | EP1090018A1 ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY |
| 04/11/2001 | CN1291228A Enzyme catalyzed therapeutic agents |
| 04/11/2001 | CN1290707A Nucleoside 5'-thiophosphoryl amino-acid ester compound |
| 04/10/2001 | US6214987 Mixture of a template-independent enzyme and a 3' blocked nucleotide 5'-triphosphate; efficient synthesis of oligo- and polynucleotides |
| 04/10/2001 | US6214812 Vitamin b6 bisphosphonate conjugate |
| 04/10/2001 | US6214807 Images and cardiovascular disorders |
| 04/10/2001 | US6214801 Imidazo[1,2-a]pyridine C-nucleosides as antiviral agents |
| 04/10/2001 | US6214551 Oligonucleoside linkages containing adjacent nitrogen atoms |
| 04/10/2001 | US6214536 Method of detecting lung disease |
| 04/05/2001 | WO2001023400A1 Highly pure guanosine 5'-diphosphate fucose and process for producing the same |
| 04/05/2001 | WO2001023399A1 Compounds for the treatment of ischemia |
| 04/05/2001 | CA2386079A1 Compounds for the treatment of ischemia |
| 04/04/2001 | EP1088823A1 Fused pyrrolocarbazoles |
| 04/04/2001 | EP1087777A2 Therapeutic dinucleotide and derivatives |
| 04/04/2001 | EP0983291A4 Carbamate-derivatized nucleosides and oligonucleosides |
| 04/04/2001 | CN1290269A 5'-deoxycytidine derivatives |
| 04/04/2001 | CN1290268A Nucleosides |
| 04/04/2001 | CN1289594A Method for treatment of diseases concerned with cytoplasmic factor |
| 04/03/2001 | US6211356 Metallocene-phosphoramidite conjugates, process for their preparation and their use |
| 04/03/2001 | US6211349 Protonated/acidified nucleic acids and methods of use |
| 04/03/2001 | US6211166 Coadministered with a 5-fluorouracil derivative; anticarcinogenic agents |
| 04/03/2001 | US6211162 Pulmonary delivery of protonated/acidified nucleic acids |
| 04/03/2001 | US6211158 Desazapurine-nucleotide derivatives, processes for the preparation thereof, pharmaceutical compositions containing them and the use thereof for nucleic acid sequencing and as antiviral agents |
| 04/03/2001 | US6210941 Methods for the detection and isolation of proteins |
| 04/03/2001 | US6210917 By treating methylthioadenosine phosphorylase deficient cells with adenine synthesis inhibitor to deplete the target cells of adenosine 5'-triphosphate |
| 04/03/2001 | CA2188147C Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 03/29/2001 | WO2000032823A9 Dna-protein fusions and uses thereof |
| 03/28/2001 | EP1086115A2 Purines and pyrimidines linked to a quencher |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |